Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $2.8 million.

  • OptimizeRx's Prepaid Assets fell 3558.9% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 3558.9%. This contributed to the annual value of $2.4 million for FY2024, which is 2542.32% down from last year.
  • OptimizeRx's Prepaid Assets amounted to $2.8 million in Q3 2025, which was down 3558.9% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Prepaid Assets registered a high of $5.6 million during Q4 2021, and its lowest value of $2.3 million during Q4 2022.
  • Over the past 5 years, OptimizeRx's median Prepaid Assets value was $3.2 million (recorded in 2023), while the average stood at $3.4 million.
  • In the last 5 years, OptimizeRx's Prepaid Assets crashed by 5949.27% in 2022 and then surged by 4586.93% in 2024.
  • Over the past 5 years, OptimizeRx's Prepaid Assets (Quarter) stood at $5.6 million in 2021, then tumbled by 59.49% to $2.3 million in 2022, then skyrocketed by 39.86% to $3.2 million in 2023, then decreased by 25.42% to $2.4 million in 2024, then grew by 18.83% to $2.8 million in 2025.
  • Its Prepaid Assets stands at $2.8 million for Q3 2025, versus $3.3 million for Q2 2025 and $2.3 million for Q1 2025.